Advancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics
Collaboration will work together to find solutions to MND within years, not decades
Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.
LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe asthma
New, multi-million pound research programme at the University of Edinburgh will develop treatments for lung infections
£1m fund to progress promising translational research addressing a medical need for children and young people